1-8 of 8
Robert Gray
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Achieving Sufficient Accrual to Address the Primary Endpoint in Phase III Clinical Trials from U.S. Cooperative Oncology Groups

Anneke T. Schroen, Gina R. Petroni, Hongkun Wang, Monika J. Thielen, Robert Gray, Jacqueline Benedetti, Xiaofei F. Wang, Daniel J. Sargent, Donald L. Wickerham, Walter Cronin, Benjamin Djulbegovic, Craig L. Slingluff, Jr
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (1): 256–262.
https://doi.org/10.1158/1078-0432.CCR-11-1633
Published: 02 January 2012
View article titled, Achieving Sufficient Accrual to Address the Primary Endpoint in Phase III Clinical Trials from U.S. Cooperative Oncology Groups
Open the PDF for Achieving Sufficient Accrual to Address the Primary Endpoint in Phase III Clinical Trials from U.S. Cooperative Oncology Groups in another window
Includes: Supplementary data
Journal Articles

Relationship between Quantitative GRB7 RNA Expression and Recurrence after Adjuvant Anthracycline Chemotherapy in Triple-Negative Breast Cancer

Joseph A. Sparano, Lori J. Goldstein, Barrett H. Childs, Steven Shak, Diana Brassard, Sunil Badve, Frederick L. Baehner, Roberto Bugarini, Steve Rowley, Edith A. Perez, Lawrence N. Shulman, Silvana Martino, Nancy E. Davidson, Paraic A. Kenny, George W. Sledge, Jr, Robert Gray
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (22): 7194–7203.
https://doi.org/10.1158/1078-0432.CCR-10-3357
Published: 14 November 2011
View article titled, Relationship between Quantitative <em>GRB7</em> RNA Expression and Recurrence after Adjuvant Anthracycline Chemotherapy in Triple-Negative Breast Cancer
Open the PDF for Relationship between Quantitative <em>GRB7</em> RNA Expression and Recurrence after Adjuvant Anthracycline Chemotherapy in Triple-Negative Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Relationship between Topoisomerase 2A RNA Expression and Recurrence after Adjuvant Chemotherapy for Breast Cancer

Joseph A. Sparano, Lori J. Goldstein, Barrett H. Childs, Steven Shak, Diana Brassard, Sunil Badve, Frederick L. Baehner, Roberto Bugarini, Steve Rowley, Edith Perez, Lawrence N. Shulman, Silvana Martino, Nancy E. Davidson, George W. Sledge, Jr., Robert Gray
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (24): 7693–7700.
https://doi.org/10.1158/1078-0432.CCR-09-1450
Published: 14 December 2009
View article titled, Relationship between Topoisomerase 2A RNA Expression and Recurrence after Adjuvant Chemotherapy for Breast Cancer
Open the PDF for Relationship between Topoisomerase 2A RNA Expression and Recurrence after Adjuvant Chemotherapy for Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Multi-Arm Clinical Trials of New Agents: Some Design Considerations

Boris Freidlin, Edward L. Korn, Robert Gray, Alison Martin
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (14): 4368–4371.
https://doi.org/10.1158/1078-0432.CCR-08-0325
Published: 15 July 2008
View article titled, Multi-Arm Clinical Trials of New Agents: Some Design Considerations
Open the PDF for Multi-Arm Clinical Trials of New Agents: Some Design Considerations in another window
Journal Articles

Development of Clinical Trials in a Cooperative Group Setting: The Eastern Cooperative Oncology Group

David M. Dilts, Alan Sandler, Steven Cheng, Joshua Crites, Lori Ferranti, Amy Wu, Robert Gray, Jean MacDonald, Donna Marinucci, Robert Comis
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (11): 3427–3433.
https://doi.org/10.1158/1078-0432.CCR-07-5060
Published: 02 June 2008
View article titled, Development of Clinical Trials in a Cooperative Group Setting: The Eastern Cooperative Oncology Group
Open the PDF for Development of Clinical Trials in a Cooperative Group Setting: The Eastern Cooperative Oncology Group in another window
Journal Articles

Cell Adhesion Molecules, Vascular Endothelial Growth Factor, and Basic Fibroblast Growth Factor in Patients with Non–Small Cell Lung Cancer Treated with Chemotherapy with or without Bevacizumab—an Eastern Cooperative Oncology Group Study

Afshin Dowlati, Robert Gray, Alan B. Sandler, Joan H. Schiller, David H. Johnson
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (5): 1407–1412.
https://doi.org/10.1158/1078-0432.CCR-07-1154
Published: 03 March 2008
View article titled, Cell Adhesion Molecules, Vascular Endothelial Growth Factor, and Basic Fibroblast Growth Factor in Patients with Non–Small Cell Lung Cancer Treated with Chemotherapy with or without Bevacizumab—an Eastern Cooperative Oncology Group Study
Open the PDF for Cell Adhesion Molecules, Vascular Endothelial Growth Factor, and Basic Fibroblast Growth Factor in Patients with Non–Small Cell Lung Cancer Treated with Chemotherapy with or without Bevacizumab—an Eastern Cooperative Oncology Group Study in another window
Includes: Supplementary data
Journal Articles

Phase II Clinical Trial Design: Methods in Translational Research from the Genitourinary Committee at the Eastern Cooperative Oncology Group

Robert Gray, Judith Manola, Scott Saxman, John Wright, Jan Dutcher, Michael Atkins, Michael Carducci, William See, Christopher Sweeney, Glenn Liu, Mark Stein, Robert Dreicer, George Wilding, Robert S. DiPaola
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (7): 1966–1969.
https://doi.org/10.1158/1078-0432.CCR-05-1136
Published: 11 April 2006
View article titled, Phase II Clinical Trial Design: Methods in Translational Research from the Genitourinary Committee at the Eastern Cooperative Oncology Group
Open the PDF for Phase II Clinical Trial Design: Methods in Translational Research from the Genitourinary Committee at the Eastern Cooperative Oncology Group in another window
Journal Articles

Evaluating Antiangiogenesis Agents in the Clinic: The Eastern Cooperative Oncology Group Portfolio of Clinical Trials

Joseph A. Sparano, Robert Gray, Bruce Giantonio, Peter O’Dwyer, Robert L. Comis
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (4): 1206–1211.
https://doi.org/10.1158/1078-0432.CCR-03-0238
Published: 20 February 2004
View article titled, Evaluating Antiangiogenesis Agents in the Clinic: <subtitle>The Eastern Cooperative Oncology Group Portfolio of Clinical Trials</subtitle>
Open the PDF for Evaluating Antiangiogenesis Agents in the Clinic: <subtitle>The Eastern Cooperative Oncology Group Portfolio of Clinical Trials</subtitle> in another window